Decreased expression of B7 costimulatory molecules and major histocompatibility complex class‐I in human hepatocellular carcinoma - Concepedia

Concepedia

Publication | Closed Access

Decreased expression of B7 costimulatory molecules and major histocompatibility complex class‐I in human hepatocellular carcinoma

58

Citations

36

References

2004

Year

Keishi Fujiwara, Toshihiro Higashi, Kazuhiro Nouso, Harushige Nakatsukasa, Yoshiyuki Kobayashi, Masayuki Uemura, Shinichiro Nakamura, Shuichiro Sato, Tadashi Hanafusa, Yasuhiro Yumoto,

Journal of Gastroenterology and Hepatology

Abstract

These findings suggest the potential role of B7 co-stimulatory molecules and HLA class-I molecules in facilitating HCC escape from immune surveillance without the involvement of IL-10.

References

	Year	Citations
Terminology of nodular hepatocellular lesions Ian R. Wanless Hepatology HepatologyNodular Hepatocellular LesionsHistopathologyHepatitisPathology	1995	1.1K
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. Lewis L. Lanier, S O'Fallon, Chamorro Somoza, The Journal of Immunology	1995	487
Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration Yoshito Wada, Osamu Nakashima, Rumiko Kutami, Hepatology	1998	396
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. Christophe Caux, Béatrice Vanbervliet, Catherine Massacrier, The Journal of Experimental Medicine Adaptive Immune SystemImmunologyImmunologic MechanismAntigen ProcessingCd4 T Cell Responses	1994	346
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generatedin vitro from CD34+ hematopoietic progenitor cells Andréas Mackensen, Birgit Herbst, Ji-Li Chen, International Journal of Cancer	2000	335
IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response J Kim, Robert L. Modlin, R L Moy, The Journal of Immunology	1995	325
Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. Masanori Matsuda, Flavio Salazar, Max Petersson, The Journal of Experimental Medicine Mhc ClassImmunologyImmune RegulationImmunologic MechanismImmune System	1994	308
Loss of MHC class‐I expression in cervical carcinomas Mary Connor, Peter L. Stern International Journal of Cancer	1990	188
Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-α) receptors in type C chronic liver disease Shinichi Kakumu, A. Okumura, Tetsuya Ishikawa, Clinical & Experimental Immunology	1997	169
Regulation of Tumor Growth and Metastasis by Interleukin-10: The Melanoma Experience Suyun Huang, Stephen E. Ullrich, Menashe Bar‐Eli Journal of Interferon & Cytokine Research	1999	160

Page 1